TRIB3 Polyclonal Antibody

The protein encoded by this gene is a putative protein kinase that is induced by the transcription factor NF-kappaB. The encoded protein is a negative regulator of NF-kappaB and can also sensitize cells to TNF- and TRAIL-induced apoptosis. In addition, this protein can negatively regulate the cell survival serine-threonine kinase AKT1. Differential promoter usage and alternate splicing result in multiple transcript variants.

The TRIB3 polyclonal antibody is a highly specific and reliable tool for the detection and analysis of TRIB3 protein expression. This antibody has been meticulously developed and rigorously validated to ensure optimal performance in various applications, including Western blotting, immunohistochemistry, and immunofluorescence.

With its exceptional sensitivity and specificity, the TRIB3 polyclonal antibody enables accurate and precise quantification of TRIB3 protein levels in a wide range of samples. Its superior affinity and selectivity towards TRIB3 make it an ideal choice for researchers aiming to investigate the role of TRIB3 in various biological processes and diseases.

The TRIB3 polyclonal antibody exhibits excellent reproducibility and consistency, ensuring reliable and robust results across multiple experiments. Its high-quality formulation guarantees minimal background noise and interference, allowing for clear and distinct visualization of TRIB3 protein bands or localization in tissues or cells.

This antibody is manufactured using state-of-the-art techniques and undergoes stringent quality control measures to ensure batch-to-batch consistency and reliability. It is supplied in a convenient and user-friendly format, with clear instructions for optimal usage and storage conditions.

In summary, the TRIB3 polyclonal antibody is a valuable tool for researchers seeking to explore the intricate functions and mechanisms of TRIB3 protein. Its exceptional specificity, sensitivity, and reliability make it an indispensable asset in various research areas, including cancer biology, metabolic disorders, and cellular signaling pathways.